Literature DB >> 2568914

Metabolism of bambuterol in rat liver microsomes: identification of hydroxylated and demethylated products by liquid chromatography mass spectrometry.

C Lindberg1, C Roos, A Tunek, L A Svensson.   

Abstract

The oxidative metabolism of (R,S)-bambuterol in rat liver microsomes was studied. Metabolite fractions were analyzed by thermospray LC-MS. The use of an equimolar mixture of deuterium-labeled and unlabeled bambuterol facilitated the mass spectrometric identification of the metabolites. Six metabolites, formed via hydroxylation, demethylation, and hydrolytic reactions, were identified. The demethylated metabolites were found to be chemically unstable under physiological conditions. It is likely that the complex biotransformation of bambuterol into terbutaline is one factor contributing to the long duration of action of bambuterol.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2568914

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  5 in total

Review 1.  Clinical pharmacokinetics of bambuterol.

Authors:  D S Sitar
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

2.  Pharmacokinetics of bambuterol during oral administration to asthmatic children.

Authors:  H Ahlström; J Alvero; R Alvero; R Espos; L Fajutrao; J Herrera; B Kjellman; J Kubista; C Leviste; P Meyer; G Oldaeus; A Siricururat; P Vichyanond; G Wettrell; E Wong; L Laxmyr; L Nyberg; H Olsson; E Weibull; J Rosenborg
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

3.  Pharmacokinetics of bambuterol in subjects homozygous for the atypical gene for plasma cholinesterase.

Authors:  U Bang; L Nyberg; J Rosenborg; J Viby-Mogensen
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

4.  Pharmacokinetics of bambuterol in healthy subjects.

Authors:  L Nyberg; J Rosenborg; E Weibull; S Jönsson; B M Kennedy; M Nilsson
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

5.  Improving the oral bioavailability of tapentadol via a carbamate prodrug approach: synthesis, bioactivation, and pharmacokinetics.

Authors:  Yingchao Li; Yongjun Wang; Ran Zhang; Cuiru Liu; Yue Wei; Jin Sun; Zhonggui He; Youjun Xu; Tianhong Zhang
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.